Bunge Global (BG)
NYSEConsumer StaplesFarm ProductsSnapshot 2026-07-08
$115.22+3.89%
Close 2026-07-08 · 1-day change
Reading BG? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BG free→NYSEConsumer StaplesFarm ProductsSnapshot 2026-07-08
Reading BG? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BG free→QuarterlyIQ Insights · BG
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 10 valuation methods, at three horizons. Current price $115.22. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $111 BG trades at 15× p/e, below its 19× p/e peer median. Our $123 fair value sits above the price. It's a high-confidence read. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 34% over what the business is worth with no growth; closing that gap needs roughly 4.0 years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $3.22/sh owner earnings.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2025-Q4, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| ddm gordon | 12M | $57.28 | — | — | TTM | high |
| graham number | 12M | $121.75 | — | — | TTM | high |
| Mgmt guidance | 12M | $175.89 | 19.0 | 9.25 | Mgmt | high |
| Peer EV/EBITDA | 12M | $81.33 | 16.6 | 9.32 | TTM | high |
| Peer P/E | 12M | $140.71 | 19.0 | 7.40 | TTM | high |
| Peer P/S | 12M | $696.08 | 1.7 | 411.51 | TTM | high |
| PEG | 12M | $363.50 | 49.1 | 7.40 | TTM | high |
| residual income | 12M | $91.90 | — | — | TTM | high |
| Own P/E history | 12M | $110.70 | 15.0 | 7.40 | TTM | high |
| triangulated | 12M | $154.62 | 19.0 | 8.13 | Triangulated | high |
| Mgmt guidance | 3Y | $389.30 | 19.0 | 20.47 | Mgmt(prov.) | medium |
| Peer P/E | 3Y | $245.35 | 19.0 | 12.90 | Analyst | medium |
| Peer P/S | 3Y | $955.16 | 1.7 | 564.68 | Analyst | medium |
| PEG | 3Y | $633.80 | 49.1 | 12.90 | Analyst | medium |
| Own P/E history | 3Y | $193.01 | 15.0 | 12.90 | Analyst | medium |
| Mgmt guidance | 5Y | $661.15 | 19.0 | 34.77 | Mgmt(prov.) | medium |
| Peer P/E | 5Y | $301.60 | 19.0 | 15.86 | Analyst | medium |
| PEG | 5Y | $779.12 | 49.1 | 15.86 | Analyst | medium |
| Own P/E history | 5Y | $237.27 | 15.0 | 15.86 | Analyst | medium |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.